Melanocortin Receptors: Ligands and Proteochemometrics Modeling

Abstract: The melanocortin receptors exist in five subtypes, MC1–5R. These receptors participate in important regulations of the immune system, central behavior, and endocrine and exocrine glands. Here we provide a short review on MCR subtype selective peptides and organic compounds with activity on the MCRs, developed in our laboratory. Also provided is an overview of our new proteochemometric modeling technology, which has been applied to model the interaction of MSH peptides with the MCRs.

[1]  T. Lundstedt,et al.  Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.

[2]  R. Petrovska,et al.  The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine. , 2001, Neuroreport.

[3]  J. Wikberg,et al.  Melanocortin receptors: new opportunities in drug discovery , 2001 .

[4]  J. Wikberg,et al.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.

[5]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[6]  T. Lundstedt,et al.  Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.

[7]  T. Lundstedt,et al.  Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors. , 2002, Protein engineering.

[8]  T. Lundstedt,et al.  PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. , 2001, Biochimica et biophysica acta.

[9]  F. Mutulis,et al.  New highly specific agonistic peptides for human melanocortin MC1 receptor☆ , 2000, Peptides.

[10]  P Herzyk,et al.  Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. , 1997, Journal of molecular graphics & modelling.

[11]  J. Wikberg,et al.  Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. , 2001, Biochemical pharmacology.

[12]  Reductive amination products containing naphthalene and indole moieties bind to melanocortin receptors. , 2002, Bioorganic & medicinal chemistry letters.

[13]  T. Lundstedt,et al.  Ligands to the melanocortin receptors , 2001 .

[14]  J Lindblom,et al.  New aspects on the melanocortins and their receptors. , 2000, Pharmacological research.

[15]  R. Petrovska,et al.  MC1 receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions , 2001, Clinical and experimental immunology.